NEW YORK (GenomeWeb) – Roche reported on Thursday a 5 percent increase in its Diagnostics division revenues for the first half of 2017, driven by strong growth in tissue diagnostics and centralized and point-of-care solutions.

For the first half ended June 30, the Swiss pharmaceuticals and diagnostics company reported sales of CHF 26.34 billion ($27.61 billion), up 5 percent from CHF 25.02 billion in the first half of 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.